Clinical Observation on Combined Therapy of Atorvastatin Calcium and Xuezhikang on Lipid-lowering

摘要

With the improvement of economic living standards and changes in people's lifestyles and eating habits, in recent years to atherosclerosis-based ischemic cardiovascular disease (including coronary heart disease and ischemic stroke) significantly increased the incidence, Hyperlipidemia is one of the risk factors for arteriosclerosis, coronary heart disease trigger factor, lower blood lipids help reduce the incidence of cardiovascular and cerebrovascular events and mortality. At present, a variety of statins lipid-lowering drug prices are more expensive, many patients difficult to adhere to long-term use. This study investigated the effects of atorvastatin and Xuezhikang capsules on lipid lowering in elderly patients with hyperlipidemia.